Pages
- Home
- Contact Us
- Chemistry at ChemPartner
- Careers
- News & Events
- Download Center
- Sitemap
- About Us
- Accolades
- Publications
- Biology & Pharmacology
- Biologics Discovery
- Discovery Chemistry
- DMPK / Exploratory Toxicology
- Molecular Pathology
- Privacy Policy
- PEPtalks2
- Introduction
- About China Gateway Biologics
- About China Gateway Pharmecutical Development
- Stable Cell Line Development
- Process Development
- Formulation Development
- Aseptic Filling and Freeze-drying
- Drug Developability / Manufacturability study
- Final Container Extractables & Leachables Study
- Analytical Development and Testing
- GMP Production
- Small Molecule CMC
- Biologics CMC
- Our Services
- ChemPartner Blog
- Thank you- Landing Page
- ADC at ChemPartner
- OncoCP Database
- Conferences 2019
News & Events
- Meeting Chiral Separation Efficiency Needs in Pharmaceutical Discovery with Supercritical Fluid Chromatography
- Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”
- Innovations in Lead Generation Through Fragment-Based Screening
- Dr. Teddy Yang appointed to Vice President and Head of Biologics Discovery at Shanghai ChemPartner
- ChemPartner Will Participate in BIO-Europe Spring in Vienna, Austria in March 2019
- ANTIBODY DISCOVERY THROUGH B CELL CLONING
- ChemPartner will be at the Boulder Peptide Symposium 2018
- Shanghai ChemPartner Announces Merger Deal Closure with Quantum
- Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery
- Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology
- The 2017 Best Life Science Contract Research Organization (CRO), ChemPartner, Chooses CAS SciFinder® to Enable Closer Collaboration with Customers
- Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation(PTF)
- ChemPartner Receives 2017 Best Life Science CRO Award from GHP
- ChemPartner Exhibits at BIOtech Japan 2017
- Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology
- ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market.
- ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner
- The 3rd Frontier Forum：New Therapeutics Discovery & Development
- ChemPartner and Trianni Announce Partnering Agreement
- ShangPharma Congratulates Morphic Therapeutic